Table 5 Comparisons of adverse events
|  | Active group (n = 69) | Control group (n = 73) | P-value |
|---|---|---|---|
Rash/allergy, n (%) | 1 (1.4) | 0 | 0.89 |
Hypoglycemia, n (%) | 1 (1.4) | 1 (1.4) | 0.72 |
Diarrhea, n (%) | 0 | 2 (2.7) | 0.93 |
Abdominal pain, n (%) | 1 (1.4) | 1 (1.4) | 0.99 |
Liver function impairment, n (%) | 0 | 0 | N/A |
Genital mycotic infection, n (%) | 3 (4.3) | 1 (1.4) | 0.15 |
Lactic acidosis, n (%) | 0 | 0 | N/A |
Diabetic ketoacidosis, n (%) | 0 | 0 | N/A |
Overall, n (%) | 6 (8.7) | 5 (6.8) | 0.50 |